Immutep Limited (ADR) share price logo

Immutep Limited (ADR)

NASDAQ: IMMP

Small Cap

$0.37

+0.02

(+4.97%)

as on

Immutep Limited (ADR) Stock Performance

as on June 18, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.36
    $0.38
    downward going graph

    2.70%

    Downside

    2.70%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.29
    $3.53
    downward going graph

    20.86%

    Downside

    854.03%

    Upside

    downward going graph

Immutep Limited (ADR) share price movements today

Previous Close
$0.36
Open
$0.36
Volume
548.6K
Day's Low - High
$0.36 - $0.38
52 Week Low - High
$0.29 - $3.53

Immutep Limited (ADR) Historical Returns

1 Month Return
-24.31 %
3 Month Return
-10.01 %
1 Year Return
-76.78 %
3 Year Return
-82.2 %
5 Year Return
-92.03 %

Immutep Limited (ADR) Stock Fundamentals & Key Indicators

Check Immutep Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$54.6M

EPS (TTM)

-0.25

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-82.4M

Revenue (TTM)

7.9M

Profit Margin

0.00%

Return On Equity TTM

-61.85%

Immutep Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immutep Limited (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Immutep Limited (ADR) image
Immutep Limited (ADR)
BUY$54.6M-92.03%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.6B59.83%71.0112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$115.0B144.34%26.8835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.4B13.01%15.0229.65%0.58%

Stock Returns calculator for Immutep Limited (ADR) Stock including INR - Dollar returns

The Immutep Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immutep Limited (ADR) investment value today

Current value as on today

₹25,080

Returns

-₹74,920

(-74.92%)

Returns from Immutep Limited (ADR) Stock

-₹77,019 (-77.02%)

Dollar Impact

₹2,099 (+2.1%)

Analyst Recommendation on Immutep Limited (ADR) Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Immutep Limited (ADR). Average target price of $1

Immutep Limited (ADR) Share Price Target

Get share price movements and forecasts by analysts on Immutep Limited (ADR).

What analysts predicted

63%UPSIDE

Target Price

$1

Current Price

$0.37

Analyzed by

9 Analysts

Target

$1.00

Immutep Limited (ADR) target price $1, a slight upside of 63% compared to current price of $0.37. According to 9 analysts rating.

Indian Investors' Interest in Immutep Limited (ADR) Stock

Search interest for Immutep Limited (ADR) Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

Immutep Limited (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Sep 2023
Dec 2023
Jun 2024
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
1
1
2
1
1
3
1
6
Gross Profit
0
0
1
-19
-19
-22
-34
-40
Operating Income
-23
-21
-43
-44
-44
-51
-74
-46
EBITDA
-20
-19
-22
-22
-22
-26
-36
-44
Interest Expense
0
0
0
0
0
-
-
0
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-20
-19
-21
-21
-21
-22
-39
-44
Income Tax Expense
0
0
0
21
21
-
-
-
Net Income
-13
-19
-21
-21
-21
-22
-39
-44
Net Profit Margin
-1223.54%
-1058.85%
-1005.72%
-1241.29%
-1241.29%
-710.92%
-2059.84%
-744.36%

Immutep Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
3
1
0
5
2
0
2
2
5
Gross Profit
-5
1
-5
-11
-10
-10
-1
0
-25
-56
Operating Income
-61
-9
-11
-20
-16
-31
-33
-77
-88
-126
EBITDA
-61
-8
-10
-16
-11
-17
-31
-39
-44
-62
Interest Expense
0
-
-
-
0
0
0
0
0
-
Depreciation
-
1
1
1
2
2
2
-
-
-
Income Before Tax
-63
-10
-12
-18
-13
-29
-32
-39
-42
-61
Income Tax Expense
-1
0
0
-2
0
0
0
0
0
-
Net Income
-45
-7
-9
-11
-9
-22
-22
-26
-28
-61
Net Profit Margin
-35426.72%
-221.89%
-484.55%
-11640.01%
-179.90%
-774.12%
-18906.51%
-1138.04%
-1111.87%
-1218.02%

Immutep Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Dec 2025
Mar 2026
Net Income
-21
-
-21
-21
-22
-
-39
-44
-
Operating Cash Flow
-17
-
-16
-7
-28
-
-33
-28
-
Investing Cash Flow
0
-
-
-20
-30
-
24
34
-
Financing Cash Flow
0
0
95
95
0
0
0
0
0
Change in Cash
-6
-8
58
66
-46
-
-73
6
-

Immutep Limited (ADR) Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-9
-12
-18
-13
-29
-32
-39
-42
-61
Operating Cash Flow
-8
-7
-15
-10
-17
-30
-35
-34
-62
Investing Cash Flow
0
0
0
0
0
0
0
-21
-38
Financing Cash Flow
0
18
8
20
52
50
76
95
0
Change in Cash
-8
11
-6
9
34
19
43
38
-94

Global Institutional Holdings in Immutep Limited (ADR)

Funds
Holdings
Rhumbline Advisers
0.01%
Group One Trading, LP
0.01%
Morgan Stanley - Brokerage Accounts
0.01%
Commonwealth Equity Services Inc
0.01%
BlackRock Inc
0.55%
See all

Immutep Limited (ADR) News & Key Events

    Insights on Immutep Limited (ADR)

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 1.89M → 6.02M (in $), with an average increase of 68.5% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Immutep Limited American Depositary Shares has experienced a drawdown of -82.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 59.8%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.4% return, outperforming this stock by 95.2%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 7 quarters, -19.27M → -44.85M (in $), with an average decrease of 17.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, IMMP stock has moved down by -24.3%

    About Immutep Limited (ADR)

    Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.
    OrganisationImmutep Limited (ADR)
    HeadquartersAustralia Square, Sydney, NSW, Australia, 2000
    IndustryBiotechnology
    CEOMr. Marc Voigt
    E-voting on sharesClick here to vote

    Key Management of Immutep Limited (ADR)

    Name

    Title

    Mr. Marc Voigt

    CEO, MD, CFO, Chief Business Officer & Executive Director

    Ms. Deanne Miller LLB

    COO, General Counsel & Joint Company Secretary

    Dr. Frederic Triebel M.D., Ph.D.

    Chief Scientific Officer & Executive Director

    Mr. Christian Mueller BBA, MSc.

    Chief Development Officer

    Dr. Stephan Winckels M.D., Ph.D.

    Chief Medical Officer

    Ms. Indira Naidu

    Joint Company Secretary

    FAQs

    What is Immutep Limited (ADR) share price today?

    Immutep Limited (ADR) share price today is $0.37 as on at the close of the market. Immutep Limited (ADR) share today touched a day high of $0.38 and a low of $0.36.

    What is the 52 week high and 52 week low for Immutep Limited (ADR) share?

    Immutep Limited (ADR) share touched a 52 week high of $3.53 on and a 52 week low of $0.29 on . Immutep Limited (ADR) stock price today i.e. is closed at $0.37,which is 89.52% down from its 52 week high and 26.37% up from its 52 week low.

    What is Immutep Limited (ADR)'s market capitalisation today?

    Immutep Limited (ADR) market capitalisation is $0.00T as on .

    How to invest in Immutep Limited (ADR) Stock (IMMP) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immutep Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immutep Limited (ADR) Shares that will get you 4.0541 shares as per Immutep Limited (ADR) share price of $0.37 per share as on June 18, 2026 at 8:46 am IST.

    What is the minimum amount required to buy Immutep Limited (ADR) Stock (IMMP) from India?

    Indian investors can start investing in Immutep Limited (ADR) (IMMP) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹943.23 in Immutep Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Immutep Limited (ADR) share’s latest price of $0.37 as on June 18, 2026 at 8:46 am IST, you will get 27.0270 shares of Immutep Limited (ADR). Learn more about fractional shares .

    What are the returns that Immutep Limited (ADR) has given to Indian investors in the last 5 years?

    Immutep Limited (ADR) stock has given -92.03% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?